FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Industries and Geographical Locations Comprising Greater than 10% of Portfolio Fair Value (Details) - USD ($) |
6 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Jun. 30, 2025 |
|||||||||||
| Concentration Risk [Line Items] | |||||||||||||
| Cost | $ 71,950,376 | [1] | $ 88,404,806 | [2] | |||||||||
| Fair Value | 63,918,767 | [3] | 85,016,596 | [4] | |||||||||
| Healthcare & Pharmaceuticals | |||||||||||||
| Concentration Risk [Line Items] | |||||||||||||
| Cost | 23,261,465 | 22,729,225 | |||||||||||
| Fair Value | $ 23,923,428 | 22,902,129 | |||||||||||
| Healthcare & Pharmaceuticals | Investments at Fair Value | Industry Concentration Risk | |||||||||||||
| Concentration Risk [Line Items] | |||||||||||||
| % of Portfolio | 37.00% | 27.00% | |||||||||||
| All Other Industries | |||||||||||||
| Concentration Risk [Line Items] | |||||||||||||
| Cost | $ 48,688,911 | 65,675,581 | |||||||||||
| Fair Value | $ 39,995,339 | $ 62,114,467 | |||||||||||
| All Other Industries | Investments at Fair Value | Industry Concentration Risk | |||||||||||||
| Concentration Risk [Line Items] | |||||||||||||
| % of Portfolio | 63.00% | 73.00% | |||||||||||
| Total | Investments at Fair Value | Industry Concentration Risk | |||||||||||||
| Concentration Risk [Line Items] | |||||||||||||
| % of Portfolio | 100.00% | 100.00% | |||||||||||
| |||||||||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cost of the investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Fair value of investment in security owned. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|